Psoriasis · San Jose

Psoriasis clinical trials in San Jose

2 recruiting psoriasis studies within range of San Jose. Click any trial for full eligibility criteria and contact info.

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

NCT07116967 · Plaque Psoriasis

Recruiting

A study to evaluate the long-term safety of Deucravacitinib versus Ustekinumab in participants with psoriasis

PhasePhase 3

TypeInterventional

Age40 Years

WhereBirmingham, Alabama, United States + 362 more

SponsorBristol-Myers Squibb

▾Tap for detailsClick for full details — eligibility, all locations, contacts

363 sitesApply

Apply Open full pageClinicalTrials.gov ↗

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

NCT06671496 · Psoriatic Arthritis

Recruiting

Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO). The main aim of the study is to know how well zasocitinib (TAK-279) works in participants with active PsA based on their previous experience with specific treatments. The participants will be treated with either zasocitinib, or placebo. Participants will be in the study for up to 60 weeks.

PhasePhase 3

TypeInterventional

Age18 Years

WhereMesa, Arizona, United States + 121 more

SponsorTakeda

▾Tap for detailsClick for full details — eligibility, all locations, contacts

122 sitesApply

Apply Open full pageClinicalTrials.gov ↗

← All psoriasis trials (nationwide)